Moreover, since heart remodeling is associated with the activation of angiotensin II or aldosterone, we investigated whether the potential effects of ivabradine in L-NAME-hypertension are related to its interference with the renin-angiotensin-aldosterone system (RAAS). Here, REN is linked to hypertensive disorder.